Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 38 Results

Title
Intervention Indication Therapeutic Area Year Actions
Abaloparatide for treating osteoporosis in males aged 40 to 85 years Abaloparatide (Tymlos; BA058) Osteoporosis Musculoskeletal System 2021 View  |  Download
Abatacept for treating idiopathic inflammatory myopathies Abatacept (Orencia) Idiopathic inflammatory myopathies Immunology , Musculoskeletal System 2022 View  |  Download
AVXS-101 for spinal muscular atrophy Onasemnogene abeparvovec (Zolgensma; AVXS-101; scAAV9.CB.SMN) Spinal muscular atrophy (SMA) Genetic Disorders , Musculoskeletal System 2018 View  |  Download
Bimekizumab for ankylosing spondylitis Bimekizumab (UCB4940) Ankylosing spondylitis Musculoskeletal System 2021 View  |  Download
Burosumab for tumour-induced osteomalacia Burosumab (Crystiva; KRN23) Osteomalacia Musculoskeletal System 2021 View  |  Download
Cethrin for traumatic spinal cord injury Cethrin (BA 210; VX-210) Spinal cord injury Musculoskeletal System 2017 View  |  Download
Clostridium botulinum neurotoxin A (Xeomin) for lower limb spasticity due to cerebral palsy – first line Botulinum toxin A (Dysport; AbobotulinumtoxinA; Xeomin; Incobotulinumtoxin A; ANT-1207; Botox; OnabotulinumtoxinA; RT002; Daxibotulinumtoxin A; Azzalure; RT-001; NT 201; AGN-151607) Lower limb spasticity Musculoskeletal System , Neurology 2017 View  |  Download
Clostridium botulinum Type A toxin (Dysport) for Spasmodic torticollis Botulinum toxin A (Dysport; AbobotulinumtoxinA; Xeomin; Incobotulinumtoxin A; ANT-1207; Botox; OnabotulinumtoxinA; RT002; Daxibotulinumtoxin A; Azzalure; RT-001; NT 201; AGN-151607) Spasmodic torticollis Musculoskeletal System , Neurology 2017 View  |  Download
Denosumab for the prevention of skeletal related events in patients with multiple myeloma – first line Denosumab (AMG 162; Prolia; Xgeva) Prevention of skeletal related events in multiple myeloma Haematological Cancer and Lymphomas , Musculoskeletal System 2017 View  |  Download
Domagrozumab (PF-6252616) for Duchenne muscular dystrophy in children and adolescents Domagrozumab (PF-06252616) Duchenne muscular dystrophy (DMD) Genetic Disorders , Musculoskeletal System 2017 View  |  Download
1 2 3 4
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications